TBCEL Inhibitors
TBCEL inhibitors are a diverse group of compounds that can indirectly lead to the inhibition of TBCEL by targeting various signaling pathways and cellular processes it may be involved in. For example, rapamycin, an mTOR inhibitor, can suppress mTORC1 activity, a complex integral to protein synthesis and cell growth. As TBCEL is implicated in the organization of the cytoskeleton, reduced mTORC1 activity can lead to compromised cytoskeletal dynamics, thereby affecting TBCEL's role within these structures. Similarly, LY294002 and staurosporine act on the PI3K/AKT and PKC pathways, respectively, which are known to influence the actin cytoskeleton and cellular dynamics, potentially leading to reduced TBCEL activity. LY294002, by inhibiting PI3K, can prevent the activation of AKT, a kinase that plays a key role in cell survival and metabolism. The alteration of this pathway can indirectly affect the cytoskeleton's integrity and function, where TBCEL might play a role.
Staurosporine, on the other hand, is a potent inhibitor of many protein kinases, including PKC. Protein kinase C is involved in various cell signaling processes, including those that regulate the cytoskeleton. By inhibiting PKC, staurosporine could disrupt the normal signaling that affects cytoskeletal organization and maintenance, which could lead to a decrease in TBCEL activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can reduce the activity of the mTORC1 complex, which is involved in protein synthesis and cell growth. Given that TBCEL is involved in cytoskeletal organization, inhibition of mTORC1 can lead to reduced cytoskeletal dynamics and potentially lessen TBCEL activity as cellular growth and cytoskeletal rearrangements are tightly linked. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor, which can influence multiple signaling pathways. By inhibiting protein kinase C (PKC), it can affect actin cytoskeleton arrangement where TBCEL may play a role, thereby potentially diminishing TBCEL's functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can block the PI3K/AKT signaling pathway. Since the AKT pathway is involved in cell survival and metabolism, blocking this pathway can indirectly influence the actin cytoskeleton and cellular dynamics, potentially leading to reduced TBCEL activity. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization, which can lead to a breakdown in actin filament formation. Because TBCEL is involved in cytoskeletal organization, the depolymerization of actin filaments can indirectly inhibit TBCEL activity by disrupting its functional substrate. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin, inhibiting its polymerization into microtubules. As TBCEL is associated with cytoskeletal dynamics, inhibiting microtubule formation can negatively impact TBCEL's function related to microtubule dynamics. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, which can prevent the phosphorylation of myosin light chains and thereby decrease cell contractility. By altering actin-myosin interactions, TBCEL's associated functions in cytoskeletal rearrangements may be indirectly inhibited due to reduced contractile forces. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin is a myosin II inhibitor that can inhibit myosin ATPase activity, leading to reduced muscle contraction and cell motility. Since TBCEL is implicated in cell structure maintenance, blebbistatin can indirectly inhibit TBCEL activity through stabilization of the cytoskeletal network. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their disassembly. This stabilization can indirectly inhibit TBCEL activity by altering the dynamics of microtubule growth and shortening, which are processes that TBCEL may be involved in. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole is a microtubule-depolymerizing agent that can disrupt microtubule networks. By preventing proper microtubule assembly, TBCEL’s function related to microtubule dynamics can be indirectly inhibited. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers and prevents their polymerization, leading to the disassembly of actin filaments. This action can indirectly inhibit TBCEL activity by altering the actin cytoskeleton structure and dynamics that TBCEL is potentially involved in. | ||||||